ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 328

IL-7; An Important Pro-Inflammatory Factor That Affects Myeloid Cell Function in RA and CIA

Nathan D. Chamberlain1, Seung-jae Kim2, Michael Volin3, Anjali Mehta2, Nadera J. Sweiss4 and Shiva Shahrara1, 1Medicine/Rheumatology, University of Illinois at Chicago, Chicago, IL, 2University of Illinois at Chicago, Chicago, IL, 3Department of Microbiology and Immunology, Chicago College of Osteopathic Medicine Midwestern University, Downers Grove, IL, 4internal medicine section of rheumatology, University of Illinois at Chicago, Chicago, IL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cytokines, Inflammation, macrophages, monocytes and rheumatoid arthritis, pathogenesis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis: Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: The aim of the study was to examine the role of IL-7 in the pathogenesis of rheumatoid arthritis (RA) as well as in collagen induced arthritis (CIA).

Methods: Linear regression analysis was employed to correlate expression of IL-7 and IL-7R with levels of DAS28 score in RA monocytes. Next, the contribution of IL-7/IL-7R to RA synovial fluid induced monocyte migration was examined by in vitro chemotaxis. Finally, CIA mice were treated therapeutically with IgG or anti-IL-7 antibodies and clinical parameters, joint proinflammatory factors, % spleen TH-1 and TH-17 cells as well as markers of bone destruction were quantified employing ELISA, FACS analysis or real-time RT-PCR.

Results: We show that patients with higher disease activity express elevated levels of IL-7 (R2=0.54, p=2.10×10-14) and IL-7R (R2=0.56, p=6.59×10-15) in 76 RA monocytes suggesting that ligation of IL-7 to IL-7R may be associated with disease progression. Next, experiments were performed to determine whether IL-7 and its receptor play a role in RA synovial fluid mediated monocyte migration. We found that neutralization of IL-7 in RA synovial fluid or blockade of IL-7R on monocytes greatly suppressed RA synovial fluid-mediated monocyte migration further documenting the importance of IL-7 and IL-7R function in myeloid cells. In order to evaluate whether IL-7 is a potential target in RA pathogenesis, CIA, a chronic murine model of RA was employed. We show that like in RA, IL-7R is significantly elevated in the lining and sublining macrophages as well as in sublining endothelial cells in CIA compared to PBS treated ankles. Additionally CIA mice produce 3 fold higher joint IL-7 levels compared to the control group. Hence to examine the role of IL-7/IL-7R in CIA pathology, CIA mice were therapeutically treated with anti-IL-7 antibody or IgG control starting on day 26 post CIA induction. These studies demonstrate that anti-IL-7 antibody treatment significantly reduced joint inflammation on days 33, 37, 40, 41 and 42 post CIA induction compared to the control group however there were no differences detected between the two treatment groups on days 28 and 30. We next found that joint TNF-a as well as ankle and serum levels of CCL2/MCP-1 were 2 fold higher in the IgG group compared to anti-IL-7 antibody treated CIA mice. We also demonstrate that anti-IL-7 treatment was capable of markedly reducing expression of markers for CIA bone erosion including RANKL (3 fold) and Cathepsin K (10 fold). In contrast the percentage of CD3, CD4, TH-1 and TH-17 positive cells was similar in anti-IL-7 and IgG treatment groups. Consistent with these findings joint IL-6 levels were unaffected by anti-IL-7 therapy while there was a trend towards lower levels of joint IL-1b and IL-17 however these values were not significantly different among the two treatment groups.

Conclusion: These novel results suggest for the first time that ligation of IL-7 to IL-7R can affect cell migration, production of proinflammatory factors and osteoclast differentiation from myeloid cells in RA as well as in experimental arthritis models.


Disclosure:

N. D. Chamberlain,
None;

S. J. Kim,
None;

M. Volin,
None;

A. Mehta,
None;

N. J. Sweiss,
None;

S. Shahrara,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/il-7-an-important-pro-inflammatory-factor-that-affects-myeloid-cell-function-in-ra-and-cia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology